ArticleInfectious diseases and therapy2023

Efficacy and Safety of Nirmatrelvir/Ritonavir, Molnupiravir, and Remdesivir in a Real-World Cohort of Outpatients with COVID-19 at High Risk of Progression: The PISA Outpatient Clinic Experience.

Giusy Tiseo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.